Overview

Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The intention of this trial is to determine the maximum tolerated of the treatment combination and to evaluate its safety and efficacy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Collaborator:
Sanofi
Treatments:
Fluorouracil
Oxaliplatin